Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis

INTRODUCTION: Given the challenges concerning the differential diagnosis of dementia, we investigated the possible added value of monoaminergic compounds to the standard cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarkers. Particularly, regarding the AD versus dementia with Lewy bodie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement (Amst)
Main Authors: Janssens, Jana, Vermeiren, Yannick, Fransen, Erik, Aerts, Tony, Van Dam, Debby, Engelborghs, Sebastiaan, De Deyn, Peter P.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2018
Assuntos:
Blood-Based Biomarkers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5852321/
https://ncbi.nlm.nih.gov/pubmed/29552632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2018.01.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados